Bank of Montreal’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-12,400
Closed -$44K 4530
2015
Q3
$44K Buy
+12,400
New +$83K ﹤0.01% 2976

Bank of Montreal's KERX Position: Q4 2018 in Review

Bank of Montreal sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 6,660 shares — an estimated $22K sold.

Bank of Montreal first reported a position in KERX in Q2 2013 and held it in 19 quarters. The position peaked at $509K in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Bank of Montreal reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Bank of Montreal sold 6,660 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $22K.
  • Bank of Montreal first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 19 quarters.
  • Bank of Montreal's Keryx Biopharmaceuticals Inc position peaked at $509K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Bank of Montreal's 13F filing for Q4 2018, filed 22 Jan 2019.